Cargando…
572. Antiviral Toxicities Among Pediatric Solid Organ Transplant Recipients
BACKGROUND: Ganciclovir (GCV) and valganciclovir (VGCV) are used for prophylaxis (PPX) and treatment for CMV in pediatric solid organ transplant (SOT) recipients, but the frequency and impact of toxicities from these medications are not well described. METHODS: Retrospective cohort study of children...
Autores principales: | Downes, Kevin J, Sharova, Anna, Mitrou, Marina, Hayes, Molly, Galetaki, Despoina, Gianchetti, Lauren, Vella, Laura A, Li, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777844/ http://dx.doi.org/10.1093/ofid/ofaa439.766 |
Ejemplares similares
-
1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
por: Sharova, Anna, et al.
Publicado: (2019) -
1745. Retrospective Cohort Analysis to Determine the Incidence of CMV Infection and Disease in Allogeneic Hematopoietic Cell Transplant Recipients at an Academic Children’s Hospital
por: Galetaki, Despoina M, et al.
Publicado: (2019) -
1762. Genotype Prevalence and Molecular Characteristics of Human Adenovirus in Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Blumenstock, Jesse, et al.
Publicado: (2019) -
Antivirals for COVID-19 in Solid Organ Transplant Recipients
por: Laracy, Justin C., et al.
Publicado: (2020) -
64. Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children
por: Downes, Kevin J, et al.
Publicado: (2021)